Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings EBITDA Margin 2010-2023 | CPHI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for China Pharma Holdings (CPHI) over the last 10 years. The current EBITDA margin for China Pharma Holdings as of December 31, 2023 is .
  
China Pharma Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.01B 0 0.00%
2023-09-30 $0.01B $-0.00B -12.50%
2023-06-30 $0.01B $-0.00B -12.50%
2023-03-31 $0.01B $-0.00B -11.11%
2022-12-31 $0.01B $-0.00B -11.11%
2022-09-30 $0.01B 0 0.00%
2022-06-30 $0.01B 0 0.00%
2022-03-31 $0.01B 0 0.00%
2021-12-31 $0.01B 0 0.00%
2021-09-30 $0.01B 0 0.00%
2021-06-30 $0.01B 0 0.00%
2021-03-31 $0.01B $0.00B 9.09%
2020-12-31 $0.01B $0.00B 9.09%
2020-09-30 $0.01B $-0.02B -154.55%
2020-06-30 $0.01B $-0.02B -154.55%
2020-03-31 $0.01B $-0.02B -180.00%
2019-12-31 $0.01B $-0.02B -163.64%
2019-09-30 $0.01B $-0.01B -63.64%
2019-06-30 $0.01B $-0.01B -72.73%
2019-03-31 $0.01B $-0.01B -72.73%
2018-12-31 $0.01B $-0.01B -58.33%
2018-09-30 $0.01B $-0.01B -100.00%
2018-06-30 $0.01B $-0.01B -92.86%
2018-03-31 $0.01B $-0.01B -100.00%
2017-12-31 $0.01B $-0.02B -115.38%
2017-09-30 $0.01B $-0.01B -35.71%
2017-06-30 $0.01B $-0.01B -35.71%
2017-03-31 $0.02B $-0.01B -33.33%
2016-12-31 $0.02B $-0.01B -31.25%
2016-09-30 $0.02B $-0.02B -100.00%
2016-06-30 $0.02B $-0.01B -64.71%
2016-03-31 $0.02B $-0.01B -42.11%
2015-12-31 $0.02B $-0.01B -52.38%
2015-09-30 $0.02B $-0.02B -94.74%
2015-06-30 $0.02B $-0.03B -133.33%
2015-03-31 $0.02B $-0.04B -180.95%
2014-12-31 $0.02B $-0.04B -168.18%
2014-09-30 $0.03B $-0.02B -88.89%
2014-06-30 $0.03B $-0.02B -68.97%
2014-03-31 $0.03B $-0.02B -51.61%
2013-12-31 $0.03B $-0.02B -53.13%
2013-09-30 $0.04B $-0.01B -27.78%
2013-06-30 $0.04B $-0.01B -15.00%
2013-03-31 $0.05B $0.00B 2.13%
2012-12-31 $0.06B $0.01B 14.55%
2012-09-30 $0.07B $0.01B 21.54%
2012-06-30 $0.07B $0.02B 24.32%
2012-03-31 $0.08B $0.02B 26.58%
2011-12-31 $0.08B $0.02B 28.40%
2011-09-30 $0.08B $0.03B 31.33%
2011-06-30 $0.08B $0.03B 33.33%
2011-03-31 $0.08B $0.03B 34.62%
2010-12-31 $0.08B $0.03B 34.67%
2010-09-30 $0.07B $0.02B 33.80%
2010-06-30 $0.07B $0.03B 36.76%
2010-03-31 $0.07B $0.02B 36.92%
2009-12-31 $0.06B $0.02B 36.51%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00